CA2621059C - Composition de protease stabilisee - Google Patents

Composition de protease stabilisee Download PDF

Info

Publication number
CA2621059C
CA2621059C CA2621059A CA2621059A CA2621059C CA 2621059 C CA2621059 C CA 2621059C CA 2621059 A CA2621059 A CA 2621059A CA 2621059 A CA2621059 A CA 2621059A CA 2621059 C CA2621059 C CA 2621059C
Authority
CA
Canada
Prior art keywords
substituted
composition according
serine protease
thrombin
stabilizing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2621059A
Other languages
English (en)
Other versions
CA2621059A1 (fr
Inventor
Lars-Olov Andersson
Hans Ageland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TROBIO AB
Original Assignee
TROBIO AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TROBIO AB filed Critical TROBIO AB
Priority claimed from PCT/SE2005/001391 external-priority patent/WO2007035143A1/fr
Publication of CA2621059A1 publication Critical patent/CA2621059A1/fr
Application granted granted Critical
Publication of CA2621059C publication Critical patent/CA2621059C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2621059A 2005-09-22 2005-09-22 Composition de protease stabilisee Expired - Fee Related CA2621059C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2005/001391 WO2007035143A1 (fr) 2004-09-21 2005-09-22 Composition de protease stabilisee

Publications (2)

Publication Number Publication Date
CA2621059A1 CA2621059A1 (fr) 2007-03-29
CA2621059C true CA2621059C (fr) 2013-08-13

Family

ID=39310896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2621059A Expired - Fee Related CA2621059C (fr) 2005-09-22 2005-09-22 Composition de protease stabilisee

Country Status (4)

Country Link
JP (1) JP5080476B2 (fr)
AU (1) AU2005336535B2 (fr)
CA (1) CA2621059C (fr)
NO (1) NO20081131L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL229134A0 (en) * 2013-10-29 2014-03-31 Omrix Biopharmaceuticals Ltd Compounds and methods for stabilizing thrombin activity
CN116850977A (zh) * 2023-07-28 2023-10-10 广州康盛生物科技股份有限公司 一种定向偶联免疫吸附剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW217410B (fr) * 1992-04-01 1993-12-11 Ciba Geigy
GB9821483D0 (en) * 1998-10-03 1998-11-25 Glaxo Group Ltd Chemical compounds
AU8875798A (en) * 1997-08-29 1999-03-22 Proteus Molecular Design Ltd Meta-benzamidine derivatives as serin protease inhibitors
JP3796340B2 (ja) * 1997-11-18 2006-07-12 株式会社ノエビア セリンプロテアーゼ阻害剤
AU2001288819A1 (en) * 2000-09-11 2002-03-26 Genentech, Inc. Amidine inhibitors of serine proteases
WO2002037937A2 (fr) * 2000-11-07 2002-05-16 Bristol-Myers Squibb Company Derives d'acides utilises comme inhibiteurs de la serine protease
GB0114005D0 (en) * 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
JP4177253B2 (ja) * 2001-08-09 2008-11-05 財団法人化学及血清療法研究所 細胞死抑制活性を有するペプチド断片を調製する方法
JP2004191367A (ja) * 2002-11-28 2004-07-08 Sysmex Corp トロンビン試薬及び検査試薬キット

Also Published As

Publication number Publication date
NO20081131L (no) 2008-06-18
AU2005336535B2 (en) 2012-05-24
AU2005336535A1 (en) 2007-03-29
JP5080476B2 (ja) 2012-11-21
JP2009508943A (ja) 2009-03-05
CA2621059A1 (fr) 2007-03-29

Similar Documents

Publication Publication Date Title
US8574569B2 (en) Stabilized protease composition
JP6486894B2 (ja) 活性剤送達のための溶解性ゲル形成フィルム
US5595735A (en) Hemostatic thrombin paste composition
JPH0764747B2 (ja) トロンビン製剤
JP2004075682A (ja) 保存に安定な液体フィブリノゲン製剤
EP3875123A1 (fr) Colle de fibrine monocomposant comprenant des zymogènes
KR20010101028A (ko) 조직 접합제용의 안정화된 단백질 제제
AU2014372152A1 (en) One component fibrin glue comprising a polymerization inhibitor
JP2010529997A (ja) 安定化トロンビン組成物
KR20020060080A (ko) 혈액 응고 제ⅶ 인자를 활성화시키는 프로테아제 또는이의 프로효소의 안정화 액제
CA2621059C (fr) Composition de protease stabilisee
DK171840B1 (da) Fibrinolysefremmende kombinationspræparater, samt anvendelse af argininderivater til fremstilling af fibrinolysefremmende præparater
US20030091558A1 (en) Storage-stable fibrinogen solutions
US20130005685A1 (en) Starch derivative mixtures
RU2388486C2 (ru) Композиция стабилизированной протеазы
US20070014780A1 (en) Storage-stable human fibrinogen solutions
KR20080059206A (ko) 안정화된 프로테아제 조성물
CN101272790A (zh) 稳定的蛋白酶组合物
KR20160060164A (ko) 메탈로프로테이나제가 연관된 병리 치료에 사용하기 위한 설로덱사이드
US20030091559A1 (en) Storage-stable human fibrinogen solutions
JP5074750B2 (ja) シクロデキストリン類を含有する液状フィブリノゲン製剤
CN102380100A (zh) 稳定的蛋白酶组合物
RU2550945C1 (ru) Гемостатическое лекарственное средство на основе синтетического трипептидного ингибитора плазмина
JPS61277614A (ja) 抗プラスミン剤
Sethi et al. Is there a surgical role for topical aprotinin?

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160922